In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Nektar Therapeutics (NKTR – Research Report). The ...

Analysts at William Blair issued their Q1 2026 earnings estimates for Enovix in a report issued on Thursday, February 20th. William Blair analyst J. Dorsheimer expects that the company will earn ...

Stock analysts at William Blair lowered their Q1 2025 EPS estimates for shares of AMN Healthcare Services in a report issued ...

Blair Murphy delved into the words of William Shakespeare not from the perspective of just a reader or even a scholar, but as ...

WJCC leaders will consider a potential name change for the school building on Longhill Road and, if approved, the ...

Commerce Secretary Howard Lutnick singled out the industry, alleging its use of foreign-flagged vessels lets companies avoid ...

This article is published as part of The Telegraph’s Greatest Interviews series, which revisits the most significant, ...

KYIV, Ukraine-The U.S. and Ukraine pushed divergent messages over the weekend, with Kyiv pressing for better terms to the mineral-rights deal sought by President Trump, while Washington urged Ukraine ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Blair Murphy delved into the words of William Shakespeare not from the perspective of just a reader or even a scholar, but as ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for General Dynamics (NYSE:GD) from ...

The U.S. Department of Defense has launched a massive review of consulting services contracts, with an eye toward making cuts ...